https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL approves a new R&D&I Quality Policy to promote excellence in healthcare research

18 de November de 2024

At the meeting of the Board of Trustees held on 29 October 2024, the Valdecilla Health Research Institute (IDIVAL) approved a new R&D&I Quality Policy, reflecting its commitment to excellence, efficiency and continuous improvement in all its research and innovation processes. This policy not only aims to strengthen support for research professionals and guarantee quality […]

Read more →

Santander iDays 2024: Fostering Innovation in Healthcare

8 de November de 2024

The Marqués de Valdecilla Research Institute (IDIVAL), in collaboration with EIT Health, held the Innovation Days (i-Days), a competition that challenges students to solve challenges in the field of innovation applied to health. The free and open event brought together more than 50 registered participants from diverse backgrounds with a common interest in technology and […]

Read more →

The IDIVAL Researchers’ Meeting Highlighted Progress and Next Steps for Pilots in the Inmobiliaria and Covadonga Neighborhoods, Torrelavega

30 de October de 2024

On September 19-20, Paloma Lanza from the Health Economics Research Group and Rosa María Cazalilla, representing the IDIVAL working team led by Dr. David Cantarero and Dr. María Jesús Cabero, attended the progress meeting for the European Health4EUkids project. The Health4EUKids Joint Action began in December 2022 with the goal of transferring the experience of […]

Read more →

IDIVAL licenses patent for DNA encapsulation technology to improve data storage and treatment of complex diseases

25 de October de 2024

IDIVAL (Marqués de Valdecilla Research Institute) is proud to announce a groundbreaking partnership with Iridia Inc., a leading technology company based in California. This collaboration aims to bring to market an innovative DNA encapsulation technology developed by the esteemed research team led by Dr. Mónica López Fanarraga at IDIVAL. The technology has the potential to […]

Read more →

Researchers from the Nanomedicine group awarded with the ‘V Prevencionar Award’ in Research

24 de October de 2024

Researchers from the Nanomedicine Group (IDIVAL-UC) have been recognised with the ‘V Prevencionar Award’ in the Research category, for their pioneering work in the study and training in Nanoprevention. This award highlights the work started in 2010 by the Nanomedicine Group, when its researchers began to explore applications of nanomaterials in various areas. Throughout their […]

Read more →

IDIVAL participates in the JACARDI General Assembly in Paris, aiming to reduce the incidence of cardiovascular diseases and diabetes in Europe

22 de October de 2024

The goals of JACARDI are to increase healthy life years, improve health equity, and reduce premature deaths in Europe. IDIVAL’s representation at this forum was led by Lorena Madrigal and Sara Barbero from the nursing research group, who presented the pilot projects they are working on as part of the initiative. The IDIVAL Health Research […]

Read more →

Care4diabetes is urgently seeking participants with type 2 diabetes to reduce medication use and optimize their lifestyle

14 de October de 2024

The European Care4Diabetes project aims to improve the quality of life of people with type 2 diabetes by focusing on 4 key elements (nutrition, physical activity, relaxation and sleep). To this end, it is looking for volunteers to participate in the “C4D-Cuido Mi Diabetes” program, designed to improve the quality of life of these people. […]

Read more →

IDIVAL receives €30,000 from Luchamos por la Vida association for cancer research

10 de October de 2024

The ‘Luchamos por la Vida’ association has presented the Valdecilla Health Research Institute (IDIVAL) with a donation of 30,000 euros, raised during its popular solidarity race, held in April in Los Corrales de Buelna. This initiative, which has been supporting the fight against cancer for more than 14 years, has earmarked the funds for two […]

Read more →

IDIVAL researchers explore the relationship between biomarkers and symptoms of persistent COVID

8 de October de 2024

Researchers from the IDIVAL nursing research group and the University of Cantabria together with the Rey Juan Carlos University and the Pneumology Service of the Marqués de Valdecilla University Hospital (HUMV), have published a new study in the journal Pathogens that addresses the relationship between biological biomarkers and the symptoms of persistent COVID, such as […]

Read more →

HUMV-IDIVAL participates in a pioneering treatment for chronic graft-versus-host disease

1 de October de 2024

The team of the Haematology Department of the Marqués de Valdecilla Hospital–IDIVAL, with Dr. Arancha Bermúdez as principal investigator, has participated in a leading international clinical trial on the treatment of chronic graft-versus-recipient disease (cGVHD). The results have recently been published in the prestigious New England Journal of Medicine. CGRID is a serious, long-term complication […]

Read more →